Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · IEX Real-Time Price · USD
10.10
-0.07 (-0.69%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Precision BioSciences Revenue

Precision BioSciences had revenue of $17.58M in the quarter ending March 31, 2024, with 100.27% growth. This brings the company's revenue in the last twelve months to $57.53M, up 88.25% year-over-year. In the year 2023, Precision BioSciences had annual revenue of $48.73M with 94.15% growth.

Revenue (ttm)
$57.53M
Revenue Growth
+88.25%
P/S Ratio
1.22
Revenue / Employee
$527,807
Employees
109
Market Cap
69.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eagle Pharmaceuticals 257.55M
Burning Rock Biotech 72.30M
Theratechnologies 60.71M
Pro-Dex 49.46M
Gritstone bio 15.65M
Celularity 14.79M
InspireMD 6.48M
Revenue Rankings